Outcome after neoadjuvant chemotherapy in elderly breast cancer patients – a pooled analysis of individual patient data from eight prospectively randomized controlled trials

INTRODUCTION: Recent studies showed the high and independent impact of age (<40 years) on pathologic complete response (pCR) and prognosis for patients undergoing neoadjuvant chemotherapy (NACT). Some physicians might not consider elderly patients (>65 years) for NACT due to poor prognosis or...

Descripción completa

Detalles Bibliográficos
Autores principales: von Waldenfels, Gabriel, Loibl, Sibylle, Furlanetto, Jenny, Machleidt, Anna, Lederer, Bianca, Denkert, Carsten, Hanusch, Claus, Kümmel, Sherko, von Minckwitz, Gunter, Schneeweiss, Andreas, Untch, Michael, Rhiem, Kerstin, Fasching, Peter A., Blohmer, Jens-Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper: Gerotarget (Focus on Aging)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880594/
https://www.ncbi.nlm.nih.gov/pubmed/29632634
http://dx.doi.org/10.18632/oncotarget.24586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880594/
https://www.ncbi.nlm.nih.gov/pubmed/29632634
http://dx.doi.org/10.18632/oncotarget.24586

Ejemplares similares